Get the app!
Back to Companies

Attovia Therapeutics, Inc.

ATTOCIK: 0002058707

Over the 19 most recent insider filings, Attovia Therapeutics, Inc. (ATTO) has seen activity from 18 distinct insiders — no open-market buying or selling. WALSH COLIN (Director) is the most active by dollar volume. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$0
Purchases
$0
Sales
$0
Unique Insiders
18

Recent Insider Trades

19 loaded
Aug 5ATTO
Attovia Therapeutics, Inc.
WALSH COLINDirectorOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
SanofiInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Vida Ventures GP III, L.L.C.InsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Topper James NInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
GOLDMAN SACHS GROUP INC10% OwnerOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
You AngieInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc.InsiderOther$0
Aug 5ATTO
Attovia Therapeutics, Inc.
Alamar HoldCo, LLCInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Odrowaz ZanetaInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
venBio Global Strategic Fund IV, L.P.InsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Veiby PetterInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Chen HubertInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Deep Track Biotechnology Master Fund, Ltd.InsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Smither John WInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Frazier Life Sciences XI, L.P.InsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Redmile Group, LLC10% OwnerOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
GOLD MITCHELLInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Royston AaronInsiderOther$0
Aug 4ATTO
Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc.InsiderOther$0

19 filings